Feb 14, 2023 4:30 pm EST Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow
Nov 8, 2022 4:30 pm EST Profound Medical to Present at the 2022 Jefferies London Healthcare Conference
Oct 13, 2022 4:30 pm EDT Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow
Sep 26, 2022 8:00 am EDT Four Year Follow-Up Data from Profound Medical’s TACT Pivotal Clinical Trial Confirm Durable and Stable Positive Trends Following Treatment with TULSA-PRO® of Men with Localized Prostate Cancer
Sep 15, 2022 8:00 am EDT Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth